Bruton’s Tyrosine Kinase (BTK) Inhibitors in Clinical Trials

Overview of attention for article published in Current Hematologic Malignancy Reports, December 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#9 of 434)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 4,082 followers.

Imbruvica, a cytoplasmic, non-receptor tyrosine kinase, inhibitor Chronic lymphocytic leukemia Breakthrough therapy http://t.co/5az2q5TbYV